Corrigendum to “Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells”

In the article titled, “Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells” [1], the authors reported that they had misspelt the name of a cell line and supplied the incorrect figure for publication. The correct name of the cell line should be Hep3B, instead of HepB3. The correct Figure 8 is displayed below. The results and conclusions described therein are not affected by these corrections.

Figure 1.

MiR-146a mimic induced apoptosis with Hoechst 33342/propidium iodide (PI) double fluorescent chromatin staining. HepG2 cells (2.5 × 10³ cells per well in a 96-well plate) were cultured for 24 h then transfected with miR-146a inhibitor, miR-146a mimic, EGFR siRNA, and their negative controls (200 nM) up to another 96 h. The effect on apoptosis was assessed and compared to mock and negative controls, ×200.